BRIEF published on 12/04/2024 at 20:28, 1 year ago 1000mercis: Public withdrawal offer initiated by Positive YmpacT AMF Cash Compensation Public Withdrawal Offer 1000thanks Positive YmpacT SAS
BRIEF published on 12/04/2024 at 19:41, 1 year ago 1000mercis Public Withdrawal Offer: Details and Regulations AMF Public Offer Financial Regulations 1000thanks Positive YmpacT
BRIEF published on 10/22/2024 at 23:59, 1 year 1 month ago Appointment of an independent expert for the 1000mercis withdrawal offer Public Offer Mandatory Withdrawal Independent Expert 1000thanks Moneta Acquisition
BRIEF published on 10/16/2024 at 11:04, 1 year 1 month ago Strategic acquisition of 1000mercis by Positive YmpacT Acquisition Public Offer 1000thanks Positive YmpacT Moneta Asset Management
BRIEF published on 09/04/2024 at 19:25, 1 year 3 months ago 1000mercis announces its half-year results as of June 30, 2024 Data Marketing 2024 Growth Half-yearly Results 1000thanks
Published on 12/05/2025 at 02:35, 3 hours 25 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 5 hours ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 6 hours 55 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 2 hours 30 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 10 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 9 hours 35 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 9 hours 45 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 10 hours 50 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 12 hours ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 12 hours 15 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 12 hours 16 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 22 hours 59 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 12 hours ago Declaration of voting rights at the end of November 2025
